Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,44 USD | -5,68% | -25,43% | -51,82% |
Omzet 2024 * | 14,8 mln. 13,65 mln. | Omzet 2025 * | 19,28 mln. 17,78 mln. | Marktkapitalisatie | 3,96 mln. 3,65 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -3 mln. -2,77 mln. | Nettowinst (verlies) 2025 * | - 0 | EV/omzet 2024 * | 0,27 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,21 x |
K/w-verhouding 2024 * |
-0,36
x | K/w-verhouding 2025 * |
3,93
x | Werknemers | 25 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 2,86% |
Recentste transcriptie over NovaBay Pharmaceuticals
1 dag | -5,68% | ||
1 week | -25,43% | ||
1 maand | +21,64% | ||
3 maanden | -32,73% | ||
6 maanden | -67,27% | ||
Lopend jaar | -51,82% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Justin Hall
CEO | Chief Executive Officer | 46 | 01-02-13 |
Tommy Law
DFI | Director of Finance/CFO | 38 | 01-12-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Paul Freiman
CHM | Chairman | 89 | 01-05-02 |
Yen You Zheng
BRD | Director/Board Member | 67 | 11-09-19 |
Bob Wu
BRD | Director/Board Member | 49 | 26-01-16 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
31-05-24 | 3,44 | -5,68% | 314 914 |
30-05-24 | 3,647 | -36,11% | 572 721 |
29-05-24 | 5,708 | +15,67% | 1 408 562 |
28-05-24 | 4,935 | +6,98% | 267 863 |
24-05-24 | 4,613 | -5,86% | 279 104 |
uitgestelde koers Nyse, 31 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-51,82% | 3,96 mln. | |
+43,36% | 54,64 mld. | |
-5,31% | 39,92 mld. | |
+37,52% | 38,82 mld. | |
+14,75% | 26,86 mld. | |
-12,56% | 26,22 mld. | |
-22,45% | 18,78 mld. | |
+0,04% | 12,16 mld. | |
+25,12% | 12,21 mld. | |
+26,04% | 11,94 mld. |